CTI BIOPHARMA CORP Insider Trading for September 2014

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in CTI BIOPHARMA CORP.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in CTI BIOPHARMA CORP for September 2014.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	BIANCO JAMES A	President and CEO	Sell	S	2.53	307,068	776,575	1,950,726	2.3 M to 2 M (-13.60 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.58	1,600	4,128	441,968	443.6 K to 442 K (-0.36 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.57	600	1,542	443,568	444.2 K to 443.6 K (-0.14 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.56	9,250	23,680	444,168	453.4 K to 444.2 K (-2.04 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.55	14,118	36,001	453,418	467.5 K to 453.4 K (-3.02 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.54	3,300	8,382	467,536	470.8 K to 467.5 K (-0.70 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.53	2,600	6,578	470,836	473.4 K to 470.8 K (-0.55 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.52	722	1,819	473,436	474.2 K to 473.4 K (-0.15 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.51	15,728	39,477	474,158	489.9 K to 474.2 K (-3.21 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.50	3,900	9,750	489,886	493.8 K to 489.9 K (-0.79 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.63	2,200	5,786	493,786	496 K to 493.8 K (-0.44 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.62	2,635	6,904	495,986	498.6 K to 496 K (-0.53 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.61	1,408	3,675	498,621	500 K to 498.6 K (-0.28 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.60	3,901	10,143	500,029	503.9 K to 500 K (-0.77 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.59	2,793	7,234	503,930	506.7 K to 503.9 K (-0.55 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.58	27,400	70,692	506,723	534.1 K to 506.7 K (-5.13 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.57	3,000	7,710	534,123	537.1 K to 534.1 K (-0.56 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.56	981	2,511	537,123	538.1 K to 537.1 K (-0.18 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.55	300	765	538,104	538.4 K to 538.1 K (-0.06 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.54	300	762	538,404	538.7 K to 538.4 K (-0.06 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.53	3,500	8,855	538,704	542.2 K to 538.7 K (-0.65 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.52	799	2,013	542,204	543 K to 542.2 K (-0.15 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.51	1,500	3,765	543,003	544.5 K to 543 K (-0.28 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.50	600	1,500	544,503	545.1 K to 544.5 K (-0.11 %)
Sep 24 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.49	500	1,245	545,103	545.6 K to 545.1 K (-0.09 %)
Sep 19 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	2.68	5,600	15,008	647,897	653.5 K to 647.9 K (-0.86 %)
Sep 19 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	2.63	100	263	653,497	653.6 K to 653.5 K (-0.02 %)
Sep 19 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	2.62	9,660	25,309	653,597	663.3 K to 653.6 K (-1.46 %)
Sep 19 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	2.61	2,300	6,003	663,257	665.6 K to 663.3 K (-0.35 %)
Sep 19 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	2.60	14,300	37,180	665,557	679.9 K to 665.6 K (-2.10 %)
Sep 19 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	2.60	3,700	9,602	679,857	683.6 K to 679.9 K (-0.54 %)
Sep 19 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	2.59	37,200	96,348	683,557	720.8 K to 683.6 K (-5.16 %)
Sep 19 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	2.59	12,200	31,537	720,757	733 K to 720.8 K (-1.66 %)
Sep 19 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	2.58	200	517	732,957	733.2 K to 733 K (-0.03 %)
Sep 19 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	2.58	59,740	154,129	733,157	792.9 K to 733.2 K (-7.53 %)
Sep 05 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.49	1,630	4,059	545,603	547.2 K to 545.6 K (-0.30 %)
Sep 05 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.49	100	249	547,233	547.3 K to 547.2 K (-0.02 %)
Sep 05 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.49	2,200	5,467	547,333	549.5 K to 547.3 K (-0.40 %)
Sep 05 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.48	8,901	22,074	549,533	558.4 K to 549.5 K (-1.59 %)
Sep 05 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.48	5,500	13,613	558,434	563.9 K to 558.4 K (-0.98 %)
Sep 05 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.47	8,870	21,909	563,934	572.8 K to 563.9 K (-1.55 %)
Sep 05 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.47	100	247	572,804	572.9 K to 572.8 K (-0.02 %)